v3.26.3
Subsequent Events
9 Months Ended
Sep. 30, 2026
Subsequent Events  
Subsequent Events

16.Subsequent Events

Achievement of Regulatory Milestone pursuant to the 2021 Xencor Agreement

In October 2026, the Company submitted its first marketing authorization application in Europe with respect to a licensed asset under the 2021 Xencor Agreement, which triggered an obligation to make a milestone payment of $7.5 million to Xencor under the 2021 Xencor Agreement. The milestone will be recognized as acquired-in-process research and development expense in the fourth quarter of 2026.